**Core Concept**
Amifostine is a cytoprotective agent that acts by inhibiting the enzyme topoisomerase II, thereby reducing the cytotoxic effects of chemotherapeutic agents on rapidly dividing cells, including the kidneys and the auditory system. It also has antioxidant properties, scavenging free radicals that can cause oxidative stress and tissue damage.

**Why the Correct Answer is Right**
Amifostine protects against nephrotoxicity, ototoxicity, and xerostomia associated with chemotherapy and radiation therapy. By reducing the formation of reactive oxygen species, amifostine maintains the integrity of the renal tubular cells, thereby preserving renal function. Additionally, amifostine prevents the damage to the hair cells of the inner ear, thereby preserving hearing and balance.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because amifostine does not protect against the cardiotoxic effects of anthracyclines. Anthracyclines cause damage to the cardiac myocytes, leading to cardiomyopathy and heart failure.
* **Option B:** This option is incorrect because amifostine does not protect against the myelosuppressive effects of chemotherapeutic agents. Amifostine does not have any direct effect on the bone marrow, and its primary mechanism of action does not involve the protection of hematopoietic cells.
* **Option C:** This option is incorrect because amifostine does not protect against the gastrointestinal toxicity of chemotherapeutic agents. While amifostine may have some protective effects on the mucosa, its primary mechanism of action does not involve the protection of the gastrointestinal tract.

**Clinical Pearl / High-Yield Fact**
Amifostine is often administered as a 15-minute infusion before chemotherapy or radiation therapy to maximize its protective effects. It is essential to note that amifostine is not a substitute for chemotherapy or radiation therapy, but rather a supportive care agent to reduce the toxicities associated with these treatments.

**Correct Answer:** D